156 related articles for article (PubMed ID: 32547514)
1. Prolyl Oligopeptidase From
Lasse C; Azevedo CS; de Araújo CN; Motta FN; Andrade MA; Rocha AP; Sampaio I; Charneau S; Gèze M; Grellier P; Santana JM; Bastos IMD
Front Microbiol; 2020; 11():1060. PubMed ID: 32547514
[No Abstract] [Full Text] [Related]
2. Leishmania infantum ecto-nucleoside triphosphate diphosphohydrolase-2 is an apyrase involved in macrophage infection and expressed in infected dogs.
Vasconcellos Rde S; Mariotini-Moura C; Gomes RS; Serafim TD; Firmino Rde C; Silva E Bastos M; Castro FF; Oliveira CM; Borges-Pereira L; de Souza AC; de Souza RF; Gómez GA; Pinheiro Ada C; Maciel TE; Silva-Júnior A; Bressan GC; Almeida MR; Baqui MM; Afonso LC; Fietto JL
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3309. PubMed ID: 25393008
[TBL] [Abstract][Full Text] [Related]
3. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819.
Venäläinen JI; Juvonen RO; Forsberg MM; Garcia-Horsman A; Poso A; Wallen EA; Gynther J; Männistö PT
Biochem Pharmacol; 2002 Aug; 64(3):463-71. PubMed ID: 12147298
[TBL] [Abstract][Full Text] [Related]
4. Activity and Cell-Death Pathway in
Scariot DB; Volpato H; Fernandes NS; Soares EFP; Ueda-Nakamura T; Dias-Filho BP; Din ZU; Rodrigues-Filho E; Rubira AF; Borges O; Sousa MDC; Nakamura CV
Front Cell Infect Microbiol; 2019; 9():208. PubMed ID: 31259161
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
6. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
7. Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
Allahverdiyev AM; Abamor ES; Bagirova M; Baydar SY; Ates SC; Kaya F; Kaya C; Rafailovich M
Exp Parasitol; 2013 Sep; 135(1):55-63. PubMed ID: 23792003
[TBL] [Abstract][Full Text] [Related]
8. Antileishmanial activities of caffeic acid phenethyl ester loaded PLGA nanoparticles against Leishmania infantum promastigotes and amastigotes in vitro.
Abamor ES
Asian Pac J Trop Med; 2017 Jan; 10(1):25-34. PubMed ID: 28107861
[TBL] [Abstract][Full Text] [Related]
9.
Portugal B; Motta FN; Correa AF; Nolasco DO; de Almeida H; Magalhães KG; Atta AL; Vieira FD; Bastos IM; Santana JM
Front Microbiol; 2017; 8():155. PubMed ID: 28223969
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
12. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
14. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
[TBL] [Abstract][Full Text] [Related]
15. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
Costa S; Machado M; Cavadas C; do Céu Sousa M
Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
[TBL] [Abstract][Full Text] [Related]
16. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
Cunha-Júnior EF; Andrade-Neto VV; Lima ML; da Costa-Silva TA; Galisteo Junior AJ; Abengózar MA; Barbas C; Rivas L; Almeida-Amaral EE; Tempone AG; Torres-Santos EC
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005281. PubMed ID: 28045892
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; Fuertes M; González M; Rubiales G; Palacios F
Eur J Med Chem; 2016 Nov; 124():740-749. PubMed ID: 27639365
[TBL] [Abstract][Full Text] [Related]
18. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone.
Mahmoudvand H; Tavakoli R; Sharififar F; Minaie K; Ezatpour B; Jahanbakhsh S; Sharifi I
Pharm Biol; 2015 Jul; 53(7):1052-7. PubMed ID: 25471014
[TBL] [Abstract][Full Text] [Related]
19. Isolation and molecular characterization of Leishmania infantum in urine from patients with visceral leishmaniasis in Brazil.
da Costa Lima MS; Hartkopf ACL; de Souza Tsujisaki RA; Oshiro ET; Shapiro JT; de Fatima Cepa Matos M; Cavalheiros Dorval ME
Acta Trop; 2018 Feb; 178():248-251. PubMed ID: 29221850
[TBL] [Abstract][Full Text] [Related]
20. In vitro antileishmanial effects of Physalis angulata root extract on Leishmania infantum.
Da Silva BJM; Pereira SWG; Rodrigues APD; Do Nascimento JLM; Silva EO
J Integr Med; 2018 Nov; 16(6):404-410. PubMed ID: 30195443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
